Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.

Delanaye P, Weekers L, Warling X, Moonen M, Smelten N, Médart L, Krzesinski JM, Cavalier E.

Nephrol Dial Transplant. 2013 Jul;28(7):1779-86. doi: 10.1093/ndt/gft001. Epub 2013 Feb 1.

PMID:
23378417
2.

Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.

Dusilová-Sulková S, Šafránek R, Vávrová J, Horáček J, Pavlíková L, Palička V.

Int Urol Nephrol. 2015 Jan;47(1):169-76. doi: 10.1007/s11255-014-0842-7. Epub 2014 Sep 28.

PMID:
25262147
3.

Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone.

Garcia-Lopes MG, Pillar R, Kamimura MA, Rocha LA, Canziani ME, Carvalho AB, Cuppari L.

Ann Nutr Metab. 2012;61(1):74-82. doi: 10.1159/000339618. Epub 2012 Aug 7.

PMID:
22889840
4.

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.

Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A.

Clin J Am Soc Nephrol. 2010 May;5(5):905-11. doi: 10.2215/CJN.06510909. Epub 2010 Mar 4.

5.

Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency.

Diamond T, Wong YK, Golombick T.

Osteoporos Int. 2013 Mar;24(3):1101-5. doi: 10.1007/s00198-012-1944-7. Epub 2012 Mar 16.

PMID:
22422304
6.

Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial.

Massart A, Debelle FD, Racapé J, Gervy C, Husson C, Dhaene M, Wissing KM, Nortier JL.

Am J Kidney Dis. 2014 Nov;64(5):696-705. doi: 10.1053/j.ajkd.2014.04.020. Epub 2014 May 22.

PMID:
24856872
7.

The same annual dose of 292000 IU of vitamin D (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D concentrations and renal function.

Pekkarinen T, Välimäki VV, Aarum S, Turpeinen U, Hämäläinen E, Löyttyniemi E, Välimäki MJ.

Clin Endocrinol (Oxf). 2010 Apr;72(4):455-61. doi: 10.1111/j.1365-2265.2009.03637.x. Epub 2009 May 25.

PMID:
19486025
8.

Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.

Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1143-9. doi: 10.2215/CJN.02840312. Epub 2013 Mar 14.

9.

Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D.

Goswami R, Gupta N, Ray D, Singh N, Tomar N.

Br J Nutr. 2008 Sep;100(3):526-9. doi: 10.1017/S0007114508921711. Epub 2008 Feb 6.

PMID:
18252022
10.

Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.

Marckmann P, Agerskov H, Thineshkumar S, Bladbjerg EM, Sidelmann JJ, Jespersen J, Nybo M, Rasmussen LM, Hansen D, Scholze A.

Nephrol Dial Transplant. 2012 Sep;27(9):3523-31. doi: 10.1093/ndt/gfs138. Epub 2012 Jul 20.

PMID:
22822092
11.

Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.

Jean G, Souberbielle JC, Chazot C.

Nephrol Dial Transplant. 2009 Dec;24(12):3799-805. doi: 10.1093/ndt/gfp370. Epub 2009 Jul 21.

PMID:
19622574
12.

High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.

Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-Letz T, Weiner SM, Rump LC.

Nephrol Dial Transplant. 2008 Dec;23(12):4016-20. doi: 10.1093/ndt/gfn367. Epub 2008 Jul 1.

PMID:
18593741
13.

Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.

Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M, Pedrazzoni M, Palummeri E, Bianchi G.

J Am Geriatr Soc. 2010 Aug;58(8):1489-95. doi: 10.1111/j.1532-5415.2010.02970.x. Epub 2010 Jul 14.

PMID:
20646099
14.

Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.

Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

Nephrol Dial Transplant. 2008 Nov;23(11):3670-6. doi: 10.1093/ndt/gfn339. Epub 2008 Jun 24.

PMID:
18579534
15.

Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.

Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.

J Ren Nutr. 2012 Mar;22(2):284-91. doi: 10.1053/j.jrn.2011.07.001. Epub 2011 Sep 10.

PMID:
21908203
16.

Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial.

Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M.

Ann Nutr Metab. 2009;54(4):291-300. doi: 10.1159/000235874. Epub 2009 Aug 31.

PMID:
19729890
17.

The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit.

Premaor MO, Scalco R, da Silva MJ, Froehlich PE, Furlanetto TW.

J Bone Miner Metab. 2008;26(6):603-8. doi: 10.1007/s00774-008-0858-0. Epub 2008 Nov 1.

PMID:
18979160
18.

Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.

Blair D, Byham-Gray L, Lewis E, McCaffrey S.

J Ren Nutr. 2008 Jul;18(4):375-82. doi: 10.1053/j.jrn.2008.04.008. Erratum in: J Ren Nutr. 2009 Mar;19(2):195.

PMID:
18558303
19.

Superiority of a high loading dose of cholecalciferol to correct hypovitaminosis d in patients with inflammatory/autoimmune rheumatic diseases.

Sainaghi PP, Bellan M, Nerviani A, Sola D, Molinari R, Cerutti C, Pirisi M.

J Rheumatol. 2013 Feb;40(2):166-72. doi: 10.3899/jrheum.120536. Epub 2012 Dec 15.

PMID:
23242183
20.

Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.

Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V.

Endocr Pract. 2008 Jan-Feb;14(1):10-7.

Supplemental Content

Support Center